CAI Q2 2016 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q2 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$72M+20.7% YoY

Gross Profit

$37M51.7% margin

Operating Income

$19M26.2% margin

Net Income

$4M5.2% margin

EPS (Diluted)

$0.19

QoQ Revenue Growth

+7.0%

Cash Flow

Operating Cash Flow

$30M

Free Cash Flow

-$54M

Stock-Based Comp.

$438,000

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$1.6B

Stockholders' Equity

$466M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$72M	$59M	+20.7%
Gross Profit	$37M	$37M	-0.9%
Operating Income	$19M	$23M	-19.6%
Net Income	$4M	$13M	-70.9%